Analytical Data
-
Gene name
atpG2
- Application
-
Alternative Names
atpG2；ATP synthase gamma chain 2. chloroplastic
-
Species
E.coli
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6LKZ7
-
Expression Region
1-291aa
-
AA Sequence
MANAKEIRTKIASVQNTQKITSAMEMVAASKMRKVQDNMAATRPYAENMRKVISHVASGSLEYKHPYLEEREAKRVAYIIISSDRGLCGGLNSNLFKRALTDMRQWQEKNVEVDLTLIGSKAISFFHRFGNVIAQTSGLGDKPKLEDLLGAVTAMLEHFDDGKIDRLYLVYNEFVNTMVQNPRITQLLPHPDKDESQDSKPNDATSRWDYIYEPDPKDILNALMLRYIESQVYQGTVESIACEQAARMVAMKSATDNAGDIINDLQLVYNKARQSAITQELSEIVAGAQAV
-
Molecular Weight
40.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The ATPG2 protein, a member of the ATP-binding cassette (ABC) transporter family, plays a crucial role in various cellular processes, particularly in the transport of ions and small molecules across cellular membranes. Its importance in human health and disease has garnered significant attention from researchers. Mutations in the ATPG2 gene have been linked to several genetic disorders, including certain forms of diabetes and metabolic syndromes, highlighting its potential as a therapeutic target. Recent advances in recombinant DNA technology have enabled the production of ATPG2 as a recombinant protein, allowing for detailed studies of its structure and function. The ability to express and purify ATPG2 in various systems, such as bacteria and yeast, has facilitated investigations into its biochemical properties, substrate specificity, and interaction with other cellular components. Moreover, the study of ATPG2 may provide insights into the mechanisms underlying ABC transporter dysfunctions, which are implicated in multidrug resistance and other pathological conditions. As such, the research on recombinant ATPG2 protein not only enhances our understanding of its biological role but also paves the way for the development of novel therapeutic strategies aimed at mitigating the effects of diseases associated with ATPG2 dysfunction.
